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Abstract 
Trim25 is a member of the tripartite motif family of E3 ubiquitin ligases. It plays major roles in innate 
immunity and defence against viral infection, control of cell proliferation and migration of cancer 
cells. Recent work identified Trim25 as being able to bind to RNA and to regulate Lin28a-mediated 
uridylation of pre-let-7. Here we review the current knowledge of the role of Trim25 in development, 
disease and RNA metabolism. 
Introduction 
The TRIpartite Motif (TRIM) family of E3 ubiquitin ligases consists of more than 70 members, all 
containing a Really Interesting New Gene (RING) zinc finger, B-Box and coiled-coil domains at the 
N-terminal end of the protein followed by a variable C-terminal which can help determine substrate 
specificity [1]. TRIM family proteins perform a variety of roles in humans, including roles in innate 
immunity and defence against viral infection, control of cell proliferation and migration of cancer 
cells. Recent work identified several members of this family, Trim25, Trim28, Trim56 and Trim71, as 
being able to bind to RNA [2-4], adding to a growing pool of RNA-binding E3 ubiquitin ligases [5]. 
E3 ubiquitin ligases catalyse the addition of ubiquitin moieties to their target proteins, which can have 
several functions depending on the type of ubiquitin chains. The most well studied of these are K48 
and K11-linked polyubiquitin chains which target proteins for degradation via the 26S proteasome, 
however others such as K63-linked polyubiquitin chains and mono-ubiquitin have been shown to have 
roles in signalling pathways, protein localisation and modulation of protein-protein interactions [6]. 
Trim25, for example, can catalyse the addition of K48 and K63-linked polyubiquitin chains and has 
roles including the targeting of the scaffold protein 14-3-3σ for degradation and as an effector of 
downstream signalling in the innate immune response to the presence of viral RNA. Our group has 
recently demonstrated that Trim25 is an RNA-dependent co-factor for the Lin28a/TuT4-mediated 
uridylation of let-7 precursors [7]. This mini-review explores the various roles of Trim25 and what we 
can learn from this multi-functional protein in the future. 
Roles of Trim25 in Development and Disease 
Trim25 in Estrogen Response and Uterine Development 
Trim25 is thought to be essential for cell proliferation and organ development in response to estrogen. 
Trim25 was first identified and designated as Estrogen-responsive Finger Protein (EFP) by the lab of 
Masami Muramatsu in a screen for regions of human genomic DNA binding to the Estrogen Receptor 
(ER) and was demonstrated to be upregulated in ER-positive mammary cells [8]. Further work by the 
same lab identified the mouse homolog of this protein and demonstrated that although mice in which 
Trim25 was disrupted were viable and fertile, uterine response to estrogen was greatly attenuated and 
the uteri of the mice were underdeveloped [9, 10]. Further investigation elucidated a possible 
mechanism for the role of Trim25 in the estrogen response. It was found that in the presence of 
estrogen Trim25 ubiquitinates ERα, both increasing its transcriptional activity by promoting 
interaction with transcriptional co-activators such as Tip60 and simultaneously targeting it for 
degradation (Figure 1) [11]. Trim25 also regulates other proteins involved in the estrogen response. 
For example, it forms part of an autoregulatory feedback loop controlling levels of the tumour 
suppressor AT-Binding transcription Factor 1 (ATBF1) (Figure 1). ATBF1 competes with ERα for 
co-activators and acts as a negative regulator of estrogen-mediated cell proliferation [12]. Trim25, 
itself upregulated in response to estrogen by ERα, acts as a negative regulator of ATBF1 by 
ubiquitinating it and targeting it for degradation. Trim25 performs a similar role regarding the 
transcription factor and TGF-β co-factor KLF5, targeting it for degradation (Figure 1) [13] .  
Trim25 in Cancer 
Trim25 has been implicated in the proliferation of many cancer cell types, often in concert with the 
estrogen response. Trim25 mRNA was detected in MCF7 (breast cancer) cells and activity at its 
promoter was increased upon estrogen addition [14]. In addition to this, tumour growth in female 
mice implanted with MCF7 cells was attenuated in a dose-dependent manner upon knockdown of 
Trim25 with antisense RNA. Further investigation showed that Trim25 was responsible for targeting 
the negative cell cycle regulator 14-3-3σ for degradation, increasing cell proliferation [15]. 
Immunohistochemical staining of breast biopsies from breast cancer patients showed that 70% of 
these tumours were positive for Trim25 expression, 50% of which were increased compared to 
adjacent normal tissue. Interestingly the same study found that expression of Trim25 did not correlate 
with the estrogen status of the tumours, indicating that Trim25 may escape from estrogen-mediated 
control of expression [16]. Moreover, Trim25 immunoreactivity was significantly correlated with 
poor prognosis of breast cancer patients [17]. Finally, the protein has been found to be overexpressed 
in several other cancer types including ovarian, gastric and lung cancers while it is downregulated in 
endometrial carcinomas [18-21]. 
Trim25 has been found to act through a variety of pathways to promote cancer cell proliferation and 
migration. For example, two recent papers have suggested a role for Trim25 in the p53/ Mouse double 
minute 2 homolog (MDM2) circuit. Knockdown of Trim25 by RNAi in lung cancer cells inhibited the 
proliferation, tumorigenesis and migration of the cells. Trim25 was subsequently shown to interact 
with p53 in both lung cancer tissues and cells and p53 levels increased upon Trim25 knockdown [18]. 
In contrast, a separate study found that Trim25 actually increased levels of both p53 and MDM2 by 
inhibiting the association of MDM2 and p300, a step necessary for the ubiquitination of p53. 
However, it was also shown that p53 activities in the promotion of apoptosis and DNA damage repair 
were attenuated in the presence of Trim25, with downregulation of Trim25 resulting in increased 
acetylation of p53 and increased apoptosis [22]. Trim25 has also been shown to act via the 
Transforming Growth Factor-β (TGF-β) pathway in gastric cancers where it aids migration and 
invasion of the cancer cells while having no effect on cell proliferation. Knockdown of Trim25 in 
these cells decreased levels of migration-associated proteins such as matrix metalloprotease-2 and -9 
and adhesion-associated proteins such as β-catenin and fibronectin 1 while levels of another adhesion-
associated protein, E-cadherin, were increased. In addition to this levels of TGF-β1 and bone 
morphogenic protein-4 were decreased upon Trim25 knockdown, while Trim25-dependent increases 
in cell migration and adhesion activities were abolished when cells were subjected to an inhibitor of 
TGF-β1 [21]. Taken together, these data indicate that Trim25 can act to stabilise proteins as well as 
target them for degradation. 
Trim25 in Innate Immunity 
Numerous proteins from the Trim family, including Trim25, have been shown to have roles in the 
Retinoc acid-Inducible Gene 1 (RIG-I) mediated interferon response to viral RNAs [23, 24]. RIG-I is 
a cytosolic Pattern Recognition Receptor (PRR), which recognises viral RNA molecules with a 5’-
triphosphate (5’ppp) [25]. Upon detection of 5’ppp-RNA, RIG-I initiates a downstream signalling 
pathway via MAVS and the protein kinases TBK1 and IKK which results in the phosphorylation-
mediated dimerization of the transcription factor IRF3, leading to type I interferon (interferon α and 
β) expression (Figure 2) [26].  
Trim25 is responsible for the K63-linked ubiquitination of one of the two CAspase Recruitment 
Domains (CARDs) of RIG-I, which is required for efficient recruitment of its downstream partner 
MAVS and therefore efficient interferon response [27]. Upon detection of 5’ppp-RNA, RIG-I 
undergoes a conformational change, which exposes the first CARD, allowing interaction with Trim25, 
which can subsequently ubiquitinate the second CARD. A mutant CARD, which does not associate 
with Trim25 is not ubiquitinated and RIG-I loses its ability for downstream signalling [28]. RIG-I can 
also be activated by CARD-dependent binding of short, unanchored polyubiquitin chains generated by 
Trim25 [29]. The ubiquitination of RIG-I by Trim25 is a target for suppression of the interferon 
response in more than one case. For example, the influenza A protein NS1 blocks the ubiquitination 
of the RIG-I CARD by Trim25, allowing the virus to avoid triggering interferon response (Figure 2) 
[30]. A mutant NS1, which cannot block ubiquitination fails to prevent RIG-I signalling and leads to 
the loss of virulence for influenza A in mice. This inhibitory activity is also greatly attenuated in an 
NS1 mutant which does not contain an RNA-binding domain, raising questions about a possible link 
between this and the RNA-binding activity of Trim25 [31]. Another mechanism for inhibition of RIG-
I ubiquitination is dependent on the linear ubiquitin assembly complex (LUBAC), containing the 
RING-IBR-RING (RBR) E3 ligases HOIP and HOIL-1L. LUBAC acts as a negative feedback 
modulator to switch off RIG-I signalling by simultaneously competing with Trim25 for RIG-I binding 
and targeting it for degradation via the proteasome (Figure 2) [32]. 
Trim25 is an RNA-binding protein 
Early experiments identified around 400 mammalian RNA Binding Proteins (RBPs) [33]. Recently 
however, the development of high through put methods such as interactome RNA-Protein (RNP) 
capture [3] allowed identification of hundreds of new RNA binding proteins, many without classical 
RNA Binding Domains (RBDs). They identified 860 RBPs in HeLa cells, half of which do not have 
canonical RBDs. This included 315 novel RNA-binding proteins that not only were not known to bind 
RNA, but have no known functional relation to RNA. Similarly Baltz et al. identified 797 RBPs in 
human embryonic kidney HEK293 cells, 245 of which were novel RBPs and 112 of these without a 
link to RNA [34]. In addition to this, Beckmann et al. identified 729 RBPs in human hepatocytic 
HuH-7 cells and, merging their results with the two previous in HeLa and HEK293 cells, concluded 
that between them they had identified 1217 human RBPs, 326 of which lack known RBDs or any 
functional relation to RNA [4]. At the moment we do not understand what most of these novel 
proteins do in relation to regulation of RNA metabolism. 
Trim25 was one of the proteins identified as a novel RBP in both Hela and HEK293 cells [3, 4] and in 
mouse Embryonic Stem Cells (mESCs) [2]. In addition, other TRIM family members were also 
identified as binding to RNA; Trim28 [34], Trim56 [3, 4, 34], and Trim71 [2, 4]. Trim25 and Trim71, 
were validated to bind RNA using different RBDs, with Trim71 using NHL repeats while Trim25 
utilises its middle section, containing the coiled coil domain. Both proteins are expressed abundantly 
in mouse ES cells and their expression pattern follows that of other stem cell specific factors (Lin28 
and Oct4) by reducing during differentiation [2].  
The importance of this was accentuated when we found that Trim25 is a co-factor in Lin28a-mediated 
uridylation of pre-let-7a-1 [7]. Lin28a is a conserved protein across many species, and it was first 
described in C. elegans, in which mutations of the protein cause defects in developmental timing and 
accelerate the differentiation of several types of cells [35]. In metazoans Lin28a is abundantly 
expressed in the early stages of embryonic development, during which it inhibits the biogenesis of 
miRNAs from the let-7 family. Lin28a expression is gradually restricted with development, which 
allows de-repression of let-7 production in more developed and differentiated cells [36-40]. The main 
mechanism by which Lin28a inhibits let-7 biogenesis is based on its interaction with the conserved 
terminal loop [41] of pre-let-7 [42-44]. This creates a platform for terminal uridylyltransferase 4 
(TUT4) and other members from the TUT family, which catalyze the reaction by adding a poly(U) tail 
to pre-let-7 [45]. Poly-uridylation ultimately results in pre-let-7 destabilization and a decrease of 
mature let-7 [45, 46]. The degradation of poly(U) pre-let-7 is performed by 3’-5’ Dis3l2 Pearlman 
syndrome exoribonuclease [47, 48], which has a preference for unstructured and poly-U-rich RNAs 
[47]. Lin28a is known to bind many miRNAs precursors, however only some are efficiently 
uridylated by the terminal uridyl transferase TUT4, leading to degradation by the exonuclease Dis3L2 
(Figure 3) [49]. We demonstrated that binding of Trim25 to the conserved terminal loop of a pre-let-
7a-1 leads to more efficient uridylation in the presence of Lin28 (Figure 3). This shows that the RNA 
binding ability of Trim25 can have a functional effect on the processing and stability of that RNA. 
Further studies are needed to determine the mechanism behind this effect, and whether the 
ubiquitination activity of Trim25 is required for this. It is possible that Trim25 ubiquitinates and 
stabilises a protein that is needed for Lin28a/TUT4-mediated uridylation, perhaps bridging between 
Lin28 and TUT4, or aiding the formation of the RNP complex. It is also possible that Trim25 
negatively regulates a protein that is blocking uridylation by ubiquitinating it and targeting it for 
degradation via the proteasome.  
To further understand what role Trim25 has as an RBP it will be important to identify what RNAs 
Trim25 binds to and what RNP complexes it interacts with, especially in the context of RIG-I 
activation by viral RNAs. It will be also crucial to understand why Trim25 has multiple roles and 
targets. We hypothesise that binding of Trim25 to RNA can lead to ubiquitination of neighbouring 
RBPs. Our working model is that when an RBPM enzyme binds RNA in the vicinity of a canonical 
RNP complex, it will modify it, thereby altering or acting to fine-tune its molecular function. 
Importantly, we hypothesise that in the context of Trim25 role in RIG-I signalling, RNA can bring 
Trim25 into closer proximity with RIG-I, allowing it to ubiquitinate RIG-I and activate downstream 
signalling pathway. Alternatively, Trim25 binding to RNA might hinder its ability to activate RIG-I 
signalling by sequestering it away from the RIG-I. In this light, it will be also interesting to verify if 
Trim25’s RNA-binding ability is important in its regulation of cell cycle or the estrogen response.  
Additionally, Trim25 is only one example of an RNA binding enzyme. Among the novel RBPs are 
several protein-modifying enzymes, such as kinases (MARK2, SRPK2, PKM1/2, ADK, FASTKD1 
and PKN2), phosphatases (PTPN1 and TNS1) and E3 ubiquitin ligases (Trim25, Trim56, Makorin 
and Roquin) [3]. This shows that the idea that Trim25 is using the RNA as a scaffold to get close to 
and modify RNP complexes might not limited to Trim proteins. This was also demonstrated by the E3 
ligases Dzip3 and Mex3b which bind the long non-coding RNA HOTAIR, which acts as an RNA 
scaffold bringing them closer to their respective substrates, Ataxin-1 and Snurportin-1, leading to their 
ubiquitination [50]. 
Identifying the RNAs and proteins that these new RNA-binding interact with will be pivotal in 
understanding their roles in development, disease and RNA metabolism. A recent genome-wide 
bioinformatic screen of the human proteome identified more than 2600 proteins with RBP signatures 
[51]. Around 30% of these are enzymes. We hypothesize that RNA-binding protein-modifying 
enzymes, such as Trim25, provide an additional layer of control over canonical RNA-binding proteins 
and can dictate and define their function. This opens the possibility for a new layer of regulation of 
RNA metabolism. 
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Figure Legends 
Figure 1. Trim25 has a role in estrogen response and protein degradation. In the presence of estrogen 
Trim25 ubiquitinates ERα, increasing its transcriptional activity by promoting interaction with 
transcriptional co-activators such as Tip60 and simultaneously targeting it for degradation. Trim25 
also targets ATBF1 and KLF5 for K48-mediated proteasome degradation. 
Figure 2. Trim25 is involved in the RIG-I/interferon pathway. Upon binding to viral 5’ppp-RNAs, 
RIG-I undergoes a conformational change that allows Trim25 to bind to one of its tandem caspase 
recruitment domains (2CARDs). Trim25 subsequently ubiquitinates the remaining CARD, leading to 
RIG-I activation and recruitment of the downstream effectors which in turn lead to expression of type 
I interferons and other antiviral proteins. Influenza A protein NS1 and endogenous linear ubiquitin 
assembly complex (LUBAC), containing the HOIP/HOIL-1L proteins inhibit Trim25 ubiquitination 
of RIG-I. 
Figure 3. Trim25 is involved in RNA metabolism. Trim25 is an RNA-dependent co-factor for the 
Lin28a/TuT4-mediated uridylation and degradation of let-7 precursors (pre-let-7). Lin28a binding to 
microRNA precursors such as pre-miR-302 does not lead to uridylation due to lack of Trim25 
binding. The ubiquitination substrates in Lin28a-mediated uridylation of pre-let-7 are not yet 
identified. 
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